Works matching IS 02692813 AND DT 2025 AND VI 61 AND IP 4

Results: 35

Editorial: Heads or Tails in the Treatment of Functional Dyspepsia—Does the Side of the Coin Matter? Authors' Reply.

Published in:

2025

By:

Chuah, Kee Huat;
Loo, Qing Yuan;
Hian, Wen Xuan;
Khoo, Xin Hui;
Panirsheeluam, Sarala;
Jubri, Nurhidayah Binti Mohammad;
Natarajan, Vicraman;
Khoo, Stanley;
Mahadeva, Sanjiv

Publication type:

Editorial

Lubiprostone Reduces Fat Content on MRI‐PDFF in Patients With MASLD: A 48‐Week Randomised Controlled Trial.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 628, doi. 10.1111/apt.18478

By:

El‐Kassas, Mohamed;
Mostafa, Hala;
Abdellatif, Wessam;
Shoman, Sohier;
Esmat, Gamal;
Brahmania, Mayur;
Liu, Hongqun;
Lee, Samuel S.

Publication type:

Article

Letter: Identifying the Best Model for Predicting Post‐SVR HCC—Authors' Reply.

Published in:

2025

By:

Shiha, Gamal;
Soliman, Riham

Publication type:

Letter to the Editor

Blood Group B May Reduce Risk of Rebleeding in Patients With Upper Gastrointestinal Haemorrhage due to Peptic Ulcer Disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 706, doi. 10.1111/apt.18485

By:

Taylor, Sarah;
Chen, Lynna;
Dutt, Krishneel;
Boyapati, Ray;
Ye, Bei;
Ong, Sim;
Kruavit, Anuk;
Lee, Nora;
Apostolov, Ross;
Suleiman, Mani;
Tacey, Mark;
Ho, Prahlad;
Gibson, Peter R.;
Garg, Mayur

Publication type:

Article

Letter: Prospective Individualised Validation of the GES in Predicting Hepatocellular Carcinoma—A 'Precision Medicine' Study: Authors' Reply.

Published in:

2025

By:

Shiha, Gamal;
Soliman, Riham

Publication type:

Letter to the Editor

Editorial: High Baseline ALT Level Confers Risk of Hepatic Adverse Events During Immune Checkpoint Inhibitors Treatment: A Call for Caution—Authors' Reply.

Published in:

2025

By:

Hung, Yi‐Ping;
Huang, Yi‐Hsiang

Publication type:

Editorial

Editorial: Individualising JAK Inhibitor Selection for Patients With Ulcerative Colitis—Authors' Reply.

Published in:

2025

By:

Akiyama, Shintaro;
Fujii, Toshimitsu

Publication type:

Case Study

Editorial: Individualising JAK Inhibitor Selection for Patients With Ulcerative Colitis.

Published in:

2025

By:

Woelfel, Simon;
Brand, Stephan

Publication type:

Editorial

Editorial: Where to Start in Ulcerative Colitis?

Published in:

2025

By:

Lee, Tanya;
Ding, Nik;
Chetwood, John David

Publication type:

Editorial

Analysis of Antroduodenal Motility in Patients With Hypermobility Spectrum Disorders/Hypermobile Ehlers–Danlos Syndrome.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 702, doi. 10.1111/apt.18471

By:

Sweerts, Kim W. E.;
Mujagic, Zlatan;
Keszthelyi, Daniel;
Conchillo, José M.

Publication type:

Article

Editorial: Evaluating the Prevalence of Metabolic Dysfunction‐Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinaemia—Authors' Reply.

Published in:

2025

By:

Amangurbanova, Maral;
Loomba, Rohit

Publication type:

Editorial

Editorial: Hepatitis D Screening—DAS (Delta Virus Awareness and Screening) Approach in Primary Care. Authors' Reply.

Published in:

2025

By:

Herta, Toni;
Joachim‐Richter, Anna;
Petroff, David;
Wiegand, Johannes

Publication type:

Editorial

Editorial: Striving for Equitable Care in Ulcerative Colitis—Authors' Reply.

Published in:

2025

By:

McFalls, Caya;
Melia, Joanna

Publication type:

Editorial

Management of Perianal Fistulizing Crohn's Disease According to Principles of Wound Repair.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 600, doi. 10.1111/apt.18466

By:

McCurdy, Jeffrey D.;
Hartley, Imogen;
Behrenbruch, Corina;
Hart, Ailsa;
Tozer, Phil;
Ding, Nik S.

Publication type:

Article

Correction to 'Editorial: Unravelling the fibres—low dietary fibre may lower risk of developing IBD'.

Published in:: 2025
Publication type:: Correction Notice

Letter: Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease—Authors' Reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 746, doi. 10.1111/apt.18464

By:

Carbery, Isabel;
Todd, Oliver;
Selinger, Christian P.

Publication type:

Article

The Proteomics of MASLD Progression: Insights From Functional Analysis to Drive the Development of New Therapeutic Solutions.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 614, doi. 10.1111/apt.18468

By:

Pirola, Carlos José;
Fernández Gianotti, Tomas;
Sookoian, Silvia

Publication type:

Article

Editorial: Heads or Tails in the Treatment of Functional Dyspepsia—Does the Side of the Coin Matter?

Published in:

2025

By:

Van de Bruaene, Cedric;
Vanuytsel, Tim

Publication type:

Editorial

Editorial: Ultralow HBsAg Levels and the Prediction of Cure in Chronic Hepatitis B—Authors' Reply.

Published in:

2025

By:

Wang, Jian;
Zhang, Shaoqiu;
Fan, Tao;
Wu, Chao;
Huang, Rui

Publication type:

Editorial

Editorial: Evaluating the Prevalence of Metabolic Dysfunction‐Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinemia.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 727, doi. 10.1111/apt.18453

By:

Bhardwaj, Nakul J.;
Kim, Rebecca G.

Publication type:

Article

Editorial: Hepatitis D Screening—DAS (Delta Virus Awareness and Screening) Approach in Primary Care.

Published in:

2025

By:

Singh, Noreen;
Ma, Mang

Publication type:

Editorial

Long‐Term Outcomes of an Infliximab‐First Versus Vedolizumab‐First Treatment Strategy in Biologic‐Naïve Patients With Ulcerative Colitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 693, doi. 10.1111/apt.18441

By:

Haynesworth, Austin;
Yeh, Kuan‐Hung;
Lee, Han Hee;
Kirkpatrick, Melissa;
Boland, Brigid S.;
Syal, Gaurav;
Xu, Ronghui;
Singh, Siddharth

Publication type:

Article

Autoimmune Hepatitis and Vitamin D Deficiency: A Nationwide Perspective.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 682, doi. 10.1111/apt.18438

By:

Kilani, Yassine;
Alsakarneh, Saqr;
Madi, Mahmoud Y.;
Mosquera, Daniel Alejandro Gonzalez;
Ferreira, Mariana Nunes;
Jaber, Fouad;
Helzberg, John;
Duong, Nikki;
Syn, Wing‐Kin

Publication type:

Article

Letter: Identifying the Best Model for Predicting Post‐SVR HCC.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 748, doi. 10.1111/apt.18437

By:

Toyoda, Hidenori

Publication type:

Article

Successful Amendment of an Existing Hepatitis B Screening Programme by a Guideline Recommended Hepatitis D Screening in the Primary Care Setting.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 651, doi. 10.1111/apt.18424

By:

Herta, Toni;
Joachim‐Richter, Anna;
Petroff, David;
Wölk, Benno;
Wolffram, Ingmar;
Berg, Thomas;
Kramer, Jan;
Bätz, Olaf;
Wiegand, Johannes

Publication type:

Article

Editorial: Ultralow HBsAg Levels and the Prediction of Cure in Chronic Hepatitis B.

Published in:

2025

By:

Hume, S. J.;
Thompson, A. J.;
Levy, M. T.

Publication type:

Editorial

In‐Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 667, doi. 10.1111/apt.18433

By:

Ferrarese, Alberto;
Zanaga, Paola;
Battistella, Sara;
Zanella, Silvia;
Zappitelli, Teresa;
Boldrin, Caterina;
Pacenti, Monia;
Cattai, Margherita;
Bordignon, Greta;
Gomiero, Federica;
Epifani, Magdalena;
Villano, Marco;
Gambato, Martina;
Zanetto, Alberto;
Cazzagon, Nora;
Chemello, Liliana;
Pasin, Francesca;
Calò, Lorenzo;
Doria, Andrea;
Trentin, Livio

Publication type:

Article

Leucine‐Rich Alpha‐2 Glycoprotein Is Associated With Transmural Inflammation Assessed by Intestinal Ultrasound in Patients With Crohn's Disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 658, doi. 10.1111/apt.18430

By:

Komatsu, Moeko;
Sagami, Shintaro;
Hojo, Aya;
Karashima, Ryo;
Maeda, Masa;
Yamana, Yoko;
Serizawa, Kanade;
Umeda, Satoko;
Asonuma, Kunio;
Nakano, Masaru;
Hibi, Toshifumi;
Matsuda, Takahisa;
Kobayashi, Taku

Publication type:

Article

Letter: Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease.

Published in:

2025

By:

Dai, Cong;
Huang, Yu‐Hong;
Jiang, Min

Publication type:

Letter to the Editor

Letter: Prospective Individualised Validation of the GES in Predicting Hepatocellular Carcinoma—A 'Precision Medicine' Study.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 741, doi. 10.1111/apt.18425

By:

Helmy, Ahmed

Publication type:

Article

Risk‐Adapted Starting Ages of Colorectal Cancer Screening for People With Diabetes or Metabolic Syndrome.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 675, doi. 10.1111/apt.18435

By:

Seum, Teresa;
Hoffmeister, Michael;
Brenner, Hermann

Publication type:

Article

Editorial: Striving for Equitable Care in Ulcerative Colitis.

Published in:

2025

By:

Barnes, Edward L.

Publication type:

Editorial

Editorial: High Baseline ALT Level Confers Risk of Hepatic Adverse Events During Immune Checkpoint Inhibitors Treatment: A Call for Caution.

Published in:

2025

By:

Zhao, Ze‐Hua;
Fan, Yu‐Chen

Publication type:

Editorial

Issue Information.

Published in:: Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 597, doi. 10.1111/apt.18072
Publication type:: Article

Management of Patients With Refractory Reflux‐Like Symptoms Despite Proton Pump Inhibitor Therapy: Evidence‐Based Consensus Statements.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 636, doi. 10.1111/apt.18420

By:

Armstrong, David;
Hungin, A. Pali;
Kahrilas, Peter J.;
Sifrim, Daniel;
Moayyedi, Paul;
Vaezi, Michael F.;
Al‐Awadhi, Sameer;
Anvari, Sama;
Bell, Reginald;
Delaney, Brendan;
Emura, Fabian;
Gyawali, C. Prakash;
Katelaris, Peter;
Lazarescu, Adriana;
Lee, Yeong Yeh;
Repici, Alessandro;
Roman, Sabine;
Rooker, Ceciel T.;
Savarino, Edoardo Vincenzo;
Sinclair, Paul

Publication type:

Article